| 2 min read
Designed to address the data challenges of acoustic dispensing, the platform captures all Echo operations within a fully digital chain of custody to improve reproducibility, traceability, and audit readiness in laboratory workflows.
| 8 min read
By combining advanced microscopy with machine learning, researchers can see how compounds affect cells in ways invisible to traditional assays.
| 2 min read
The new Carterra Vega HT-SPR system combines 48 parallel channels with high-resolution binding data, enabling primary screening at a scale previously unattainable with label-free technologies.Industry Perspectives
| 1 min read
Applications are now open for the 2026 Eppendorf & Science Prize for Neurobiology, marking the award’s 25th anniversary and recognizing exceptional early-career researchers in the field.
| 3 min read
Intranasal nose-to-brain delivery achieves superior brain exposure with low systemic burden, outperforming transporter-based BBB technologies in preclinical studies.
| 1 min read
Refeyn earns a place on The Sunday Times 100 Tech list, highlighting strong growth in bioanalytical instrumentation.
| 3 min read
The Atlas will enable the validation of genetic targets and training of AI models at unprecedented scale
| 1 min read
A new pilot under BioMed X’s XBridge framework aims to connect Harvard investigators with pharmaceutical researchers through structured matchmaking and sponsored research agreements.
| 2 min read
New grant boosts global access to biotherapeutics, leveraging advanced molecular design and reducing monoclonal antibody costs.
| 2 min read
New GlycoLiner kits enable rapid, covalent labeling of live-cell surface glycoproteins using gentle, self-catalyzing chemistry at neutral pH.
| 2 min read
ProBioGen will apply its CHO.RiGHT platform and GlymaxX technology to support Spica’s first clinical candidate, the anti-CD163 antibody ST101.
| 2 min read
The milestone marks meaningful progress toward developing new therapeutic options for Alport syndrome, with first-patient dosing expected in early 2026.
